Tirzepatide

Buy Tirzepatide in Canada from Legacy Laboratories. Tirzepatide is a first-in-class dual agonist that activates both the GIP and GLP-1 receptors, marketed pharmaceutically as Mounjaro and Zepbound.

What Is Tirzepatide?

Tirzepatide combines two incretin mechanisms in a single molecule, which is associated with greater metabolic effect than GLP-1 activation alone. See its DrugBank entry.

How Tirzepatide Works

By activating glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, Tirzepatide enhances insulin secretion, suppresses appetite, and slows gastric emptying.

Research & Potential Benefits

• Significant body-weight reduction in the SURMOUNT trials
• Robust blood-glucose and HbA1c improvement (SURPASS trials)
• Strong, sustained appetite suppression

Review the clinical evidence on PubMed.

Stacking Tirzepatide

Tirzepatide is studied alongside Cagrilintide and classic metabolic agents such as Clenbuterol and Cytomel (T3).

Important Information

The information above is provided for educational and research purposes only and has not been evaluated by Health Canada or the U.S. Food & Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease. Semaglutide and Tirzepatide are prescription medications in many jurisdictions; nothing here is medical advice. Always consult a licensed healthcare professional before beginning any new compound.